Global PET Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 13 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global PET Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for PET Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PET Radiopharmaceuticals that contribute to its increasing demand across many markets.

The global PET Radiopharmaceuticals market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global PET Radiopharmaceuticals total production and demand, 2018-2029, (K Pcs)
Global PET Radiopharmaceuticals total production value, 2018-2029, (USD Million)
Global PET Radiopharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global PET Radiopharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Pcs)
U.S. VS China: PET Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global PET Radiopharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Pcs)
Global PET Radiopharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global PET Radiopharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
This reports profiles key players in the global PET Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada) and Advanced Accelerator Applications S.A. (France), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PET Radiopharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global PET Radiopharmaceuticals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global PET Radiopharmaceuticals Market, Segmentation by Type
    F-18
    Ru-82
    Others

Global PET Radiopharmaceuticals Market, Segmentation by Application
    Oncology
    Cardiology
    Neurology
    Others

Companies Profiled:
    Cardinal Health Inc. (U.S.)
    Mallinckrodt plc (Ireland)
    GE Healthcare (U.K.)
    Lantheus Medical Imaging, Inc. (U.S.)
    Bayer AG (Germany)
    Bracco Imaging S.p.A (Italy)
    Eczacibasi-Monrol Nuclear Products (Turkey)
    Nordion, Inc. (Canada)
    Advanced Accelerator Applications S.A. (France)
    IBA Molecular Imaging (Belgium)

Key Questions Answered
1. How big is the global PET Radiopharmaceuticals market?
2. What is the demand of the global PET Radiopharmaceuticals market?
3. What is the year over year growth of the global PET Radiopharmaceuticals market?
4. What is the production and production value of the global PET Radiopharmaceuticals market?
5. Who are the key producers in the global PET Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 PET Radiopharmaceuticals Introduction
    1.2 World PET Radiopharmaceuticals Supply & Forecast
        1.2.1 World PET Radiopharmaceuticals Production Value (2018 & 2022 & 2029)
        1.2.2 World PET Radiopharmaceuticals Production (2018-2029)
        1.2.3 World PET Radiopharmaceuticals Pricing Trends (2018-2029)
    1.3 World PET Radiopharmaceuticals Production by Region (Based on Production Site)
        1.3.1 World PET Radiopharmaceuticals Production Value by Region (2018-2029)
        1.3.2 World PET Radiopharmaceuticals Production by Region (2018-2029)
        1.3.3 World PET Radiopharmaceuticals Average Price by Region (2018-2029)
        1.3.4 North America PET Radiopharmaceuticals Production (2018-2029)
        1.3.5 Europe PET Radiopharmaceuticals Production (2018-2029)
        1.3.6 China PET Radiopharmaceuticals Production (2018-2029)
        1.3.7 Japan PET Radiopharmaceuticals Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 PET Radiopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 PET Radiopharmaceuticals Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World PET Radiopharmaceuticals Demand (2018-2029)
    2.2 World PET Radiopharmaceuticals Consumption by Region
        2.2.1 World PET Radiopharmaceuticals Consumption by Region (2018-2023)
        2.2.2 World PET Radiopharmaceuticals Consumption Forecast by Region (2024-2029)
    2.3 United States PET Radiopharmaceuticals Consumption (2018-2029)
    2.4 China PET Radiopharmaceuticals Consumption (2018-2029)
    2.5 Europe PET Radiopharmaceuticals Consumption (2018-2029)
    2.6 Japan PET Radiopharmaceuticals Consumption (2018-2029)
    2.7 South Korea PET Radiopharmaceuticals Consumption (2018-2029)
    2.8 ASEAN PET Radiopharmaceuticals Consumption (2018-2029)
    2.9 India PET Radiopharmaceuticals Consumption (2018-2029)

3 World PET Radiopharmaceuticals Manufacturers Competitive Analysis
    3.1 World PET Radiopharmaceuticals Production Value by Manufacturer (2018-2023)
    3.2 World PET Radiopharmaceuticals Production by Manufacturer (2018-2023)
    3.3 World PET Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
    3.4 PET Radiopharmaceuticals Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global PET Radiopharmaceuticals Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for PET Radiopharmaceuticals in 2022
        3.5.3 Global Concentration Ratios (CR8) for PET Radiopharmaceuticals in 2022
    3.6 PET Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.6.1 PET Radiopharmaceuticals Market: Region Footprint
        3.6.2 PET Radiopharmaceuticals Market: Company Product Type Footprint
        3.6.3 PET Radiopharmaceuticals Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: PET Radiopharmaceuticals Production Value Comparison
        4.1.1 United States VS China: PET Radiopharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: PET Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: PET Radiopharmaceuticals Production Comparison
        4.2.1 United States VS China: PET Radiopharmaceuticals Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: PET Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: PET Radiopharmaceuticals Consumption Comparison
        4.3.1 United States VS China: PET Radiopharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: PET Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based PET Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers PET Radiopharmaceuticals Production Value (2018-2023)
        4.4.3 United States Based Manufacturers PET Radiopharmaceuticals Production (2018-2023)
    4.5 China Based PET Radiopharmaceuticals Manufacturers and Market Share
        4.5.1 China Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers PET Radiopharmaceuticals Production Value (2018-2023)
        4.5.3 China Based Manufacturers PET Radiopharmaceuticals Production (2018-2023)
    4.6 Rest of World Based PET Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers PET Radiopharmaceuticals Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers PET Radiopharmaceuticals Production (2018-2023)

5 Market Analysis by Type
    5.1 World PET Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 F-18
        5.2.2 Ru-82
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World PET Radiopharmaceuticals Production by Type (2018-2029)
        5.3.2 World PET Radiopharmaceuticals Production Value by Type (2018-2029)
        5.3.3 World PET Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World PET Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Oncology
        6.2.2 Cardiology
        6.2.3 Neurology
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World PET Radiopharmaceuticals Production by Application (2018-2029)
        6.3.2 World PET Radiopharmaceuticals Production Value by Application (2018-2029)
        6.3.3 World PET Radiopharmaceuticals Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Cardinal Health Inc. (U.S.)
        7.1.1 Cardinal Health Inc. (U.S.) Details
        7.1.2 Cardinal Health Inc. (U.S.) Major Business
        7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services
        7.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Cardinal Health Inc. (U.S.) Recent Developments/Updates
        7.1.6 Cardinal Health Inc. (U.S.) Competitive Strengths & Weaknesses
    7.2 Mallinckrodt plc (Ireland)
        7.2.1 Mallinckrodt plc (Ireland) Details
        7.2.2 Mallinckrodt plc (Ireland) Major Business
        7.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services
        7.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Mallinckrodt plc (Ireland) Recent Developments/Updates
        7.2.6 Mallinckrodt plc (Ireland) Competitive Strengths & Weaknesses
    7.3 GE Healthcare (U.K.)
        7.3.1 GE Healthcare (U.K.) Details
        7.3.2 GE Healthcare (U.K.) Major Business
        7.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services
        7.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GE Healthcare (U.K.) Recent Developments/Updates
        7.3.6 GE Healthcare (U.K.) Competitive Strengths & Weaknesses
    7.4 Lantheus Medical Imaging, Inc. (U.S.)
        7.4.1 Lantheus Medical Imaging, Inc. (U.S.) Details
        7.4.2 Lantheus Medical Imaging, Inc. (U.S.) Major Business
        7.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services
        7.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
        7.4.6 Lantheus Medical Imaging, Inc. (U.S.) Competitive Strengths & Weaknesses
    7.5 Bayer AG (Germany)
        7.5.1 Bayer AG (Germany) Details
        7.5.2 Bayer AG (Germany) Major Business
        7.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Product and Services
        7.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Bayer AG (Germany) Recent Developments/Updates
        7.5.6 Bayer AG (Germany) Competitive Strengths & Weaknesses
    7.6 Bracco Imaging S.p.A (Italy)
        7.6.1 Bracco Imaging S.p.A (Italy) Details
        7.6.2 Bracco Imaging S.p.A (Italy) Major Business
        7.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services
        7.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Bracco Imaging S.p.A (Italy) Recent Developments/Updates
        7.6.6 Bracco Imaging S.p.A (Italy) Competitive Strengths & Weaknesses
    7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
        7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Details
        7.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Major Business
        7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services
        7.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
        7.7.6 Eczacibasi-Monrol Nuclear Products (Turkey) Competitive Strengths & Weaknesses
    7.8 Nordion, Inc. (Canada)
        7.8.1 Nordion, Inc. (Canada) Details
        7.8.2 Nordion, Inc. (Canada) Major Business
        7.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services
        7.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Nordion, Inc. (Canada) Recent Developments/Updates
        7.8.6 Nordion, Inc. (Canada) Competitive Strengths & Weaknesses
    7.9 Advanced Accelerator Applications S.A. (France)
        7.9.1 Advanced Accelerator Applications S.A. (France) Details
        7.9.2 Advanced Accelerator Applications S.A. (France) Major Business
        7.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services
        7.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
        7.9.6 Advanced Accelerator Applications S.A. (France) Competitive Strengths & Weaknesses
    7.10 IBA Molecular Imaging (Belgium)
        7.10.1 IBA Molecular Imaging (Belgium) Details
        7.10.2 IBA Molecular Imaging (Belgium) Major Business
        7.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services
        7.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 IBA Molecular Imaging (Belgium) Recent Developments/Updates
        7.10.6 IBA Molecular Imaging (Belgium) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 PET Radiopharmaceuticals Industry Chain
    8.2 PET Radiopharmaceuticals Upstream Analysis
        8.2.1 PET Radiopharmaceuticals Core Raw Materials
        8.2.2 Main Manufacturers of PET Radiopharmaceuticals Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 PET Radiopharmaceuticals Production Mode
    8.6 PET Radiopharmaceuticals Procurement Model
    8.7 PET Radiopharmaceuticals Industry Sales Model and Sales Channels
        8.7.1 PET Radiopharmaceuticals Sales Model
        8.7.2 PET Radiopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World PET Radiopharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World PET Radiopharmaceuticals Production Value by Region (2018-2023) & (USD Million)
    Table 3. World PET Radiopharmaceuticals Production Value by Region (2024-2029) & (USD Million)
    Table 4. World PET Radiopharmaceuticals Production Value Market Share by Region (2018-2023)
    Table 5. World PET Radiopharmaceuticals Production Value Market Share by Region (2024-2029)
    Table 6. World PET Radiopharmaceuticals Production by Region (2018-2023) & (K Pcs)
    Table 7. World PET Radiopharmaceuticals Production by Region (2024-2029) & (K Pcs)
    Table 8. World PET Radiopharmaceuticals Production Market Share by Region (2018-2023)
    Table 9. World PET Radiopharmaceuticals Production Market Share by Region (2024-2029)
    Table 10. World PET Radiopharmaceuticals Average Price by Region (2018-2023) & (USD/Pcs)
    Table 11. World PET Radiopharmaceuticals Average Price by Region (2024-2029) & (USD/Pcs)
    Table 12. PET Radiopharmaceuticals Major Market Trends
    Table 13. World PET Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Pcs)
    Table 14. World PET Radiopharmaceuticals Consumption by Region (2018-2023) & (K Pcs)
    Table 15. World PET Radiopharmaceuticals Consumption Forecast by Region (2024-2029) & (K Pcs)
    Table 16. World PET Radiopharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key PET Radiopharmaceuticals Producers in 2022
    Table 18. World PET Radiopharmaceuticals Production by Manufacturer (2018-2023) & (K Pcs)
    Table 19. Production Market Share of Key PET Radiopharmaceuticals Producers in 2022
    Table 20. World PET Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 21. Global PET Radiopharmaceuticals Company Evaluation Quadrant
    Table 22. World PET Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and PET Radiopharmaceuticals Production Site of Key Manufacturer
    Table 24. PET Radiopharmaceuticals Market: Company Product Type Footprint
    Table 25. PET Radiopharmaceuticals Market: Company Product Application Footprint
    Table 26. PET Radiopharmaceuticals Competitive Factors
    Table 27. PET Radiopharmaceuticals New Entrant and Capacity Expansion Plans
    Table 28. PET Radiopharmaceuticals Mergers & Acquisitions Activity
    Table 29. United States VS China PET Radiopharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China PET Radiopharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 31. United States VS China PET Radiopharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 32. United States Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers PET Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers PET Radiopharmaceuticals Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers PET Radiopharmaceuticals Production (2018-2023) & (K Pcs)
    Table 36. United States Based Manufacturers PET Radiopharmaceuticals Production Market Share (2018-2023)
    Table 37. China Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers PET Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers PET Radiopharmaceuticals Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers PET Radiopharmaceuticals Production (2018-2023) & (K Pcs)
    Table 41. China Based Manufacturers PET Radiopharmaceuticals Production Market Share (2018-2023)
    Table 42. Rest of World Based PET Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers PET Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers PET Radiopharmaceuticals Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers PET Radiopharmaceuticals Production (2018-2023) & (K Pcs)
    Table 46. Rest of World Based Manufacturers PET Radiopharmaceuticals Production Market Share (2018-2023)
    Table 47. World PET Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World PET Radiopharmaceuticals Production by Type (2018-2023) & (K Pcs)
    Table 49. World PET Radiopharmaceuticals Production by Type (2024-2029) & (K Pcs)
    Table 50. World PET Radiopharmaceuticals Production Value by Type (2018-2023) & (USD Million)
    Table 51. World PET Radiopharmaceuticals Production Value by Type (2024-2029) & (USD Million)
    Table 52. World PET Radiopharmaceuticals Average Price by Type (2018-2023) & (USD/Pcs)
    Table 53. World PET Radiopharmaceuticals Average Price by Type (2024-2029) & (USD/Pcs)
    Table 54. World PET Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World PET Radiopharmaceuticals Production by Application (2018-2023) & (K Pcs)
    Table 56. World PET Radiopharmaceuticals Production by Application (2024-2029) & (K Pcs)
    Table 57. World PET Radiopharmaceuticals Production Value by Application (2018-2023) & (USD Million)
    Table 58. World PET Radiopharmaceuticals Production Value by Application (2024-2029) & (USD Million)
    Table 59. World PET Radiopharmaceuticals Average Price by Application (2018-2023) & (USD/Pcs)
    Table 60. World PET Radiopharmaceuticals Average Price by Application (2024-2029) & (USD/Pcs)
    Table 61. Cardinal Health Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
    Table 62. Cardinal Health Inc. (U.S.) Major Business
    Table 63. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services
    Table 64. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Cardinal Health Inc. (U.S.) Recent Developments/Updates
    Table 66. Cardinal Health Inc. (U.S.) Competitive Strengths & Weaknesses
    Table 67. Mallinckrodt plc (Ireland) Basic Information, Manufacturing Base and Competitors
    Table 68. Mallinckrodt plc (Ireland) Major Business
    Table 69. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services
    Table 70. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Mallinckrodt plc (Ireland) Recent Developments/Updates
    Table 72. Mallinckrodt plc (Ireland) Competitive Strengths & Weaknesses
    Table 73. GE Healthcare (U.K.) Basic Information, Manufacturing Base and Competitors
    Table 74. GE Healthcare (U.K.) Major Business
    Table 75. GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services
    Table 76. GE Healthcare (U.K.) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GE Healthcare (U.K.) Recent Developments/Updates
    Table 78. GE Healthcare (U.K.) Competitive Strengths & Weaknesses
    Table 79. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
    Table 80. Lantheus Medical Imaging, Inc. (U.S.) Major Business
    Table 81. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services
    Table 82. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
    Table 84. Lantheus Medical Imaging, Inc. (U.S.) Competitive Strengths & Weaknesses
    Table 85. Bayer AG (Germany) Basic Information, Manufacturing Base and Competitors
    Table 86. Bayer AG (Germany) Major Business
    Table 87. Bayer AG (Germany) PET Radiopharmaceuticals Product and Services
    Table 88. Bayer AG (Germany) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Bayer AG (Germany) Recent Developments/Updates
    Table 90. Bayer AG (Germany) Competitive Strengths & Weaknesses
    Table 91. Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base and Competitors
    Table 92. Bracco Imaging S.p.A (Italy) Major Business
    Table 93. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services
    Table 94. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Bracco Imaging S.p.A (Italy) Recent Developments/Updates
    Table 96. Bracco Imaging S.p.A (Italy) Competitive Strengths & Weaknesses
    Table 97. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Manufacturing Base and Competitors
    Table 98. Eczacibasi-Monrol Nuclear Products (Turkey) Major Business
    Table 99. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services
    Table 100. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
    Table 102. Eczacibasi-Monrol Nuclear Products (Turkey) Competitive Strengths & Weaknesses
    Table 103. Nordion, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
    Table 104. Nordion, Inc. (Canada) Major Business
    Table 105. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services
    Table 106. Nordion, Inc. (Canada) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Nordion, Inc. (Canada) Recent Developments/Updates
    Table 108. Nordion, Inc. (Canada) Competitive Strengths & Weaknesses
    Table 109. Advanced Accelerator Applications S.A. (France) Basic Information, Manufacturing Base and Competitors
    Table 110. Advanced Accelerator Applications S.A. (France) Major Business
    Table 111. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services
    Table 112. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
    Table 114. IBA Molecular Imaging (Belgium) Basic Information, Manufacturing Base and Competitors
    Table 115. IBA Molecular Imaging (Belgium) Major Business
    Table 116. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services
    Table 117. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of PET Radiopharmaceuticals Upstream (Raw Materials)
    Table 119. PET Radiopharmaceuticals Typical Customers
    Table 120. PET Radiopharmaceuticals Typical Distributors
List of Figure
    Figure 1. PET Radiopharmaceuticals Picture
    Figure 2. World PET Radiopharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World PET Radiopharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World PET Radiopharmaceuticals Production (2018-2029) & (K Pcs)
    Figure 5. World PET Radiopharmaceuticals Average Price (2018-2029) & (USD/Pcs)
    Figure 6. World PET Radiopharmaceuticals Production Value Market Share by Region (2018-2029)
    Figure 7. World PET Radiopharmaceuticals Production Market Share by Region (2018-2029)
    Figure 8. North America PET Radiopharmaceuticals Production (2018-2029) & (K Pcs)
    Figure 9. Europe PET Radiopharmaceuticals Production (2018-2029) & (K Pcs)
    Figure 10. China PET Radiopharmaceuticals Production (2018-2029) & (K Pcs)
    Figure 11. Japan PET Radiopharmaceuticals Production (2018-2029) & (K Pcs)
    Figure 12. PET Radiopharmaceuticals Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 15. World PET Radiopharmaceuticals Consumption Market Share by Region (2018-2029)
    Figure 16. United States PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 17. China PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 18. Europe PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 19. Japan PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 20. South Korea PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 21. ASEAN PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 22. India PET Radiopharmaceuticals Consumption (2018-2029) & (K Pcs)
    Figure 23. Producer Shipments of PET Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for PET Radiopharmaceuticals Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for PET Radiopharmaceuticals Markets in 2022
    Figure 26. United States VS China: PET Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: PET Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: PET Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers PET Radiopharmaceuticals Production Market Share 2022
    Figure 30. China Based Manufacturers PET Radiopharmaceuticals Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers PET Radiopharmaceuticals Production Market Share 2022
    Figure 32. World PET Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World PET Radiopharmaceuticals Production Value Market Share by Type in 2022
    Figure 34. F-18
    Figure 35. Ru-82
    Figure 36. Others
    Figure 37. World PET Radiopharmaceuticals Production Market Share by Type (2018-2029)
    Figure 38. World PET Radiopharmaceuticals Production Value Market Share by Type (2018-2029)
    Figure 39. World PET Radiopharmaceuticals Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 40. World PET Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World PET Radiopharmaceuticals Production Value Market Share by Application in 2022
    Figure 42. Oncology
    Figure 43. Cardiology
    Figure 44. Neurology
    Figure 45. Others
    Figure 46. World PET Radiopharmaceuticals Production Market Share by Application (2018-2029)
    Figure 47. World PET Radiopharmaceuticals Production Value Market Share by Application (2018-2029)
    Figure 48. World PET Radiopharmaceuticals Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 49. PET Radiopharmaceuticals Industry Chain
    Figure 50. PET Radiopharmaceuticals Procurement Model
    Figure 51. PET Radiopharmaceuticals Sales Model
    Figure 52. PET Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global PET Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global PET Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 17 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global PET Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global PET Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global PET Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global PET Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

PET Radiopharmaceuticals

SPECT and PET Radiopharmaceuticals

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>